Amplitude Surgical SA (EPA: AMPLI)

Market Cap	154.52M
Revenue (ttm)	104.05M
Net Income (ttm)	43.23M
Shares Out	47.99M
EPS (ttm)	0.90
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,103
Open	3.120
Previous Close	3.120
Day's Range	3.120 - 3.240
52-Week Range	2.700 - 3.680
Beta	0.52
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 2, 2024

About Amplitude Surgical

Amplitude Surgical SA develops and markets products for orthopedic surgery. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. In addition, the company provides instruments for fit...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1997
• Employees: 416
• Stock Exchange: Euronext Paris
• Ticker Symbol: AMPLI

Financial Performance

In 2023, CATG's revenue was 207.33 million, an increase of 39.55% compared to the previous year's 148.58 million. Earnings were 19.35 million, an increase of 21.68%.